Sen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, launched an investigation Wednesday into the “outrageously high prices” of Novo ...
Price Action: Novo Nordisk's stock closed 0.35% up at $128.40 on Friday, according to Benzinga Pro. Read Next: Bernie Sanders Calls For 32-Hour Workweek Without Pay Cut: ‘The Time Is Long Overdue’ ...
Senator Bernie Sanders is upping the pressure on Danish drugmaker Novo Nordisk A/S to lower the cost of its blockbuster weight-loss drug Wegovy, warning in a new report that if prices don’t come ...
Novo Nordisk A/S is asking for more time to answer questions from US Senator Bernie Sanders on the prices of Ozempic and Wegovy, the company’s blockbuster drugs for diabetes and weight loss ...
(Bloomberg) -- Senator Bernie Sanders wants to meet next week with Novo Nordisk A/S’s top executive about lowering the price ...
Although new weight-loss drugs such as Wegovy and Ozempic are effective, they also are prohibitively expensive. Sen. Bernie Sanders, I-Vt., wants to know why. He demanded answers in a recent ...
Ozempic and Wegovy maker Novo Nordisk should be forced to cut the price of its obesity and diabetes wonder drugs, Bernie Sanders has said, claiming the current costs are “outrageously high”.
“The scientists at Novo Nordisk deserve great credit for developing these drugs that have the potential to be a game changer for millions of Americans struggling with type 2 diabetes and obesity.
WASHINGTON — Bernie Sanders is figuring out just how far bullying drugmakers can take him. For more than a year, Sanders has used his perch atop the Senate health committee to haul the CEOs of ...
Senator Bernie Sanders is upping the pressure on Danish drugmaker Novo Nordisk A/S to lower the cost of its blockbuster weight-loss drug Wegovy, warning in a new report that if prices don’t come ...